🟢 Veraxa Biotech is trading 6.19% up in after-hours trading; catalyst remains unclear

Veraxa Biotech is trading at $1.20, +6.19%, while the reason for its after-hours rise remains unclear.

• The stock closed at $1.13, up 15.31% on October 29.
• Schwab listed no company headlines that day, and the latest investor-relations releases were dated October 13.
• The broad market was lower, so its weakness does not explain the stock’s after-hours rise.